Back to results
US 2019/0167619 A1Published application
Pharmaceutical formulations and their use
AssigneeSignum Biosciences, Inc.
InventorsMichael VORONKOV, Gareth WINCKLE
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeSignum Biosciences, Inc.
InventorsMichael VORONKOV, Gareth WINCKLE
Estimating the term…
A pharmaceutical composition comprising (a) at least one protective agent selected from the group consisting of butylated hydroxyanisole, butylated hydroxytoluene, sodium metabisulfite, tert-butylhydroquinone, methylparaben, propylparaben, benzyl alcohol, poly(acrylic acid), hydroxyethyl cellulose, emulsifying wax, PEG-21 stearyl ether, PEG-2 stearyl ether, white petrolatum, myristyl lactate, diisopropyl adipate, cetyl alcohol, cyclomethicone, oleyl alcohol, cholesterol, and polyoxyethylene(4)lauryl ether; and (b) a therapeutically effective amount of an IPC Active Agent or a pharmaceutically acceptable salt or ester thereof.
A pharmaceutical composition comprising (a) at least one protective agent selected from the group consisting of butylated hydroxyanisole, butylated hydroxytoluene, sodium metabisulfite, tert-butylhydroquinone, methylparaben, propylparaben, benzyl alcohol, poly(acrylic acid), hydroxyethyl cellulose, emulsifying wax, PEG-21 stearyl ether, PEG-2 stearyl ether, white petrolatum, myristyl lactate, diisopropyl adipate, cetyl alcohol, cyclomethicone, oleyl alcohol, cholesterol, and polyoxyethylene(4)lauryl ether;
20-21. (canceled)
(canceled)
27-28. (canceled)
(canceled)
34-35. (canceled)
(canceled)
Dependencies are inferred from the claim text.